[
  {
    "title": "我武生物(300357.SZ)：联营公司在研产品获得I期(多次给药)临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2022/12/26160937238081.shtml",
    "datetime": "2022-12-26 16:09:49",
    "code": "300357"
  },
  {
    "title": "我武生物：联营公司在研产品获得I期（多次给药）临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2022/12/26160937238080.shtml",
    "datetime": "2022-12-26 16:09:19",
    "code": "300357"
  },
  {
    "title": "我武生物：决定终止“尘螨合剂”研发项目",
    "href": "http://stock.jrj.com.cn/2022/11/29173037174881.shtml",
    "datetime": "2022-11-29 17:30:19",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：控股股东拟参与转融通证券出借业务、参与股份不超523.584万股",
    "href": "http://stock.jrj.com.cn/2022/11/01185037104207.shtml",
    "datetime": "2022-11-01 18:50:30",
    "code": "300357"
  },
  {
    "title": "我武生物2022年前三季度净利3.27亿同比增长19.16% 政府补助增加",
    "href": "http://stock.jrj.com.cn/2022/10/25185037082660.shtml",
    "datetime": "2022-10-25 18:50:46",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)第三季度净利1.46亿元 同比增长14.82%",
    "href": "http://stock.jrj.com.cn/2022/10/25165937081943.shtml",
    "datetime": "2022-10-25 16:59:57",
    "code": "300357"
  },
  {
    "title": "我武生物：Q2受疫情影响拖累业绩增速，诊疗新产品有望成为增长新动力",
    "href": "http://stock.jrj.com.cn/hotstock/2022/08/30075836950527.shtml",
    "datetime": "2022-08-30 07:58:03",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)拟2.92亿元投建干细胞创新技术及产业化(一期)项目",
    "href": "http://stock.jrj.com.cn/2022/08/26003636938112.shtml",
    "datetime": "2022-08-26 00:36:41",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)上半年净利1.81亿元，同比增长22.92%",
    "href": "http://stock.jrj.com.cn/2022/08/25171736936093.shtml",
    "datetime": "2022-08-25 17:17:44",
    "code": "300357"
  },
  {
    "title": "我武生物2022年上半年净利1.81亿同比增长23% 脱敏诊疗市场规模扩大",
    "href": "http://stock.jrj.com.cn/2022/07/20223136830094.shtml",
    "datetime": "2022-07-20 22:31:06",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)业绩快报：上半年净利升22.96%至1.81亿元",
    "href": "http://stock.jrj.com.cn/2022/07/20184536829440.shtml",
    "datetime": "2022-07-20 18:45:09",
    "code": "300357"
  },
  {
    "title": "我武生物：股东胡赓熙减持563.60万股 占公司总股本比例1.0764%",
    "href": "http://stock.jrj.com.cn/2022/06/23173836753778.shtml",
    "datetime": "2022-06-23 17:38:29",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：实控人近日大宗交易减持1.0764%股份",
    "href": "http://stock.jrj.com.cn/2022/06/23170136753538.shtml",
    "datetime": "2022-06-23 17:01:34",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：实控人胡赓熙拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/06/14190836728667.shtml",
    "datetime": "2022-06-14 19:08:06",
    "code": "300357"
  },
  {
    "title": "我武生物：实控人拟大宗交易减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/06/14181536728436.shtml",
    "datetime": "2022-06-14 18:15:08",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)2021年度权益分派10派2.01元 股权登记日为6月15日",
    "href": "http://stock.jrj.com.cn/2022/06/09192936716891.shtml",
    "datetime": "2022-06-09 19:29:12",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：“皮炎诊断贴剂01贴”药物临床试验申请获批",
    "href": "http://stock.jrj.com.cn/2022/06/08201936713697.shtml",
    "datetime": "2022-06-08 20:19:39",
    "code": "300357"
  },
  {
    "title": "我武生物2022年第一季度净利9173.54万同比增加30.21% 其他收益增加",
    "href": "http://stock.jrj.com.cn/2022/05/02171136533005.shtml",
    "datetime": "2022-05-02 17:11:53",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：向特定对象发行股票注册批复到期失效",
    "href": "http://stock.jrj.com.cn/2022/04/15162336344781.shtml",
    "datetime": "2022-04-15 16:23:30",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：皮炎诊断贴剂01贴药物临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/03/21155534855739.shtml",
    "datetime": "2022-03-21 15:55:31",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：黄花蒿花粉变应原舌下滴剂上市后临床试验首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/03/16160034834269.shtml",
    "datetime": "2022-03-16 16:00:13",
    "code": "300357"
  },
  {
    "title": "我武生物业绩恢复增长 “单腿走路”现状仍未改变",
    "href": "http://stock.jrj.com.cn/2022/02/14121134426990.shtml",
    "datetime": "2022-02-14 12:11:00",
    "code": "300357"
  },
  {
    "title": "我武生物业绩恢复增长 “单腿走路”现状仍未改变",
    "href": "http://stock.jrj.com.cn/2022/02/14121134344161.shtml",
    "datetime": "2022-02-14 12:11:00",
    "code": "300357"
  },
  {
    "title": "我武生物2021年净利3.38亿同比增长21.46% 市场有效需求不断增长",
    "href": "http://stock.jrj.com.cn/2022/02/11211034326649.shtml",
    "datetime": "2022-02-11 21:10:54",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)业绩快报：2021年度净利润升21.46%至3.38亿元",
    "href": "http://stock.jrj.com.cn/2022/02/11191434324525.shtml",
    "datetime": "2022-02-11 19:14:55",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：黄花蒿花粉变应原舌下滴剂新增儿童适应症获受理",
    "href": "http://stock.jrj.com.cn/2022/02/08163634306944.shtml",
    "datetime": "2022-02-08 16:36:07",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2022/01/26212134225167.shtml",
    "datetime": "2022-01-26 21:21:51",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：获得黄花蒿花粉变应原舌下滴剂儿童鼻炎III期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2022/01/24183934205653.shtml",
    "datetime": "2022-01-24 18:39:55",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：“葎草花粉点刺液”的上市许可申请已获正式受理",
    "href": "http://stock.jrj.com.cn/2022/01/13163234154062.shtml",
    "datetime": "2022-01-13 16:32:05",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：获得葎草花粉点刺液III期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2021/12/27211234072534.shtml",
    "datetime": "2021-12-27 21:12:37",
    "code": "300357"
  },
  {
    "title": "A股异动 | 我武生物(300357.SZ)放量涨超7% 获得三项药物III期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2021/11/15102533853203.shtml",
    "datetime": "2021-11-15 10:25:23",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：获得白桦花粉点刺液III期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2021/11/12175033841767.shtml",
    "datetime": "2021-11-12 17:50:43",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：获得变应原皮肤点刺试验对照液III期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2021/11/12174833841751.shtml",
    "datetime": "2021-11-12 17:48:41",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：获得黄花蒿花粉点刺液III期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2021/11/12174633841685.shtml",
    "datetime": "2021-11-12 17:46:31",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：第三季度净利升4.26%至1.27亿元",
    "href": "http://stock.jrj.com.cn/2021/10/26175533755715.shtml",
    "datetime": "2021-10-26 17:55:39",
    "code": "300357"
  },
  {
    "title": "我武生物2021年前三季度净利2.75亿元 同比净利增加19.84%",
    "href": "http://stock.jrj.com.cn/2021/10/26164233754928.shtml",
    "datetime": "2021-10-26 16:42:52",
    "code": "300357"
  },
  {
    "title": "我武生物跌6.39% 申银万国海通证券高点唱多",
    "href": "http://stock.jrj.com.cn/2021/10/14172233691779.shtml",
    "datetime": "2021-10-14 17:22:00",
    "code": "300357"
  },
  {
    "title": "我武生物2021年半年度净利1.47亿元 同比净利增加37.61%",
    "href": "http://stock.jrj.com.cn/2021/08/26202133326626.shtml",
    "datetime": "2021-08-26 20:21:25",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)半年度净利润1.47亿元 同比增长37.61%",
    "href": "http://stock.jrj.com.cn/2021/08/26202033326593.shtml",
    "datetime": "2021-08-26 20:20:07",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：子公司以200万元收购凯屹医药1%股权并对其增资4345万元",
    "href": "http://stock.jrj.com.cn/2021/08/02194933190451.shtml",
    "datetime": "2021-08-02 19:49:52",
    "code": "300357"
  },
  {
    "title": "A股异动 | 上半年业绩符预期 我武生物(300357.SZ)放量涨7%",
    "href": "http://stock.jrj.com.cn/2021/07/16143133107194.shtml",
    "datetime": "2021-07-16 14:31:25",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)业绩快报：半年度净利润升37.61%至1.47亿元",
    "href": "http://stock.jrj.com.cn/2021/07/15155933101682.shtml",
    "datetime": "2021-07-15 15:59:36",
    "code": "300357"
  },
  {
    "title": "我武生物业绩快报：上半年净利润1.47亿元 同比增38%",
    "href": "http://stock.jrj.com.cn/2021/07/15155533101666.shtml",
    "datetime": "2021-07-15 15:55:35",
    "code": "300357"
  },
  {
    "title": "我武生物：公司天然药物领域相关研发项目处于活性化合物确定与优化的研究阶段",
    "href": "http://stock.jrj.com.cn/2021/06/24194632991210.shtml",
    "datetime": "2021-06-24 19:46:04",
    "code": "300357"
  },
  {
    "title": "我武生物：公司暂未有集中带量采购的品种",
    "href": "http://stock.jrj.com.cn/2021/06/21181032970613.shtml",
    "datetime": "2021-06-21 18:10:37",
    "code": "300357"
  },
  {
    "title": "我武生物：公司产品黄花蒿花粉变应原舌下滴剂学术推广等销售工作正在逐步推进中",
    "href": "http://stock.jrj.com.cn/2021/06/18151032954523.shtml",
    "datetime": "2021-06-18 15:10:58",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：胡赓熙质押160万股及解押175万股",
    "href": "http://stock.jrj.com.cn/2021/06/10174332906032.shtml",
    "datetime": "2021-06-10 17:43:47",
    "code": "300357"
  },
  {
    "title": "我武生物：5%以上股东部分股份质押及解除质押",
    "href": "http://stock.jrj.com.cn/2021/06/10165432906109.shtml",
    "datetime": "2021-06-10 16:54:44",
    "code": "300357"
  },
  {
    "title": "我武生物：公司产品黄花蒿花粉变应原舌下滴剂学术推广等销售工作正在逐步推进中",
    "href": "http://stock.jrj.com.cn/2021/06/08185732894942.shtml",
    "datetime": "2021-06-08 18:57:56",
    "code": "300357"
  },
  {
    "title": "我武生物：公司暂未考虑开发去除人脸部螨虫相关药物",
    "href": "http://stock.jrj.com.cn/2021/06/01183932858372.shtml",
    "datetime": "2021-06-01 18:39:30",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：拟使用超募资金建设变应原点刺液原液技术改造项目",
    "href": "http://stock.jrj.com.cn/2021/05/31195132851953.shtml",
    "datetime": "2021-05-31 19:51:32",
    "code": "300357"
  },
  {
    "title": "我武生物：公司天然药物研发项目目前正处在候选化合物确定阶段",
    "href": "http://stock.jrj.com.cn/2021/05/31153832849804.shtml",
    "datetime": "2021-05-31 15:38:12",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)2020年度权益分派10派1.6元 股权登记日为5月31日",
    "href": "http://stock.jrj.com.cn/2021/05/25224532818850.shtml",
    "datetime": "2021-05-25 22:45:54",
    "code": "300357"
  },
  {
    "title": "我武生物：公司已完成首个干细胞治疗药物的中试生产",
    "href": "http://stock.jrj.com.cn/2021/05/24164532811022.shtml",
    "datetime": "2021-05-24 16:45:22",
    "code": "300357"
  },
  {
    "title": "我武生物：黄花蒿花粉变应原舌下滴剂已于5月上旬向医药商业公司（药品经营企业）发货",
    "href": "http://stock.jrj.com.cn/2021/05/24155032810660.shtml",
    "datetime": "2021-05-24 15:50:18",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：公司药品生产许可证增加生产范围",
    "href": "http://stock.jrj.com.cn/2021/05/20142932786989.shtml",
    "datetime": "2021-05-20 14:29:49",
    "code": "300357"
  },
  {
    "title": "我武生物：公司是目前国内唯一一家生产销售舌下尘螨脱敏制剂的企业",
    "href": "http://stock.jrj.com.cn/2021/05/10130432728366.shtml",
    "datetime": "2021-05-10 13:04:41",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：定增申请获中证监注册批复",
    "href": "http://stock.jrj.com.cn/2021/04/25152132437639.shtml",
    "datetime": "2021-04-25 15:21:39",
    "code": "300357"
  },
  {
    "title": "我武生物：截止目前黄花蒿花粉变应原舌下滴剂尚未开始正式销售",
    "href": "http://stock.jrj.com.cn/2021/04/22175932424571.shtml",
    "datetime": "2021-04-22 17:59:28",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2021/04/07160132325402.shtml",
    "datetime": "2021-04-07 16:01:04",
    "code": "300357"
  },
  {
    "title": "我武生物：公司产品“黄花蒿花粉变应原舌下滴剂”生产线目前处于GMP符合性检查过程中",
    "href": "http://stock.jrj.com.cn/2021/03/17162932151386.shtml",
    "datetime": "2021-03-17 16:29:58",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：定增申请收到深交所意见告知函",
    "href": "http://stock.jrj.com.cn/2021/03/10195632105238.shtml",
    "datetime": "2021-03-10 19:56:01",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：定增募资额拟由不超7.25亿元调至不超6.6亿元",
    "href": "http://stock.jrj.com.cn/2021/03/08222832093406.shtml",
    "datetime": "2021-03-08 22:28:13",
    "code": "300357"
  },
  {
    "title": "我武生物跌8.9%股价连跌 高点申银万国海通证券唱多",
    "href": "http://stock.jrj.com.cn/2021/03/08175932092070.shtml",
    "datetime": "2021-03-08 17:59:00",
    "code": "300357"
  },
  {
    "title": "A股异动 | 我武生物(300357.SZ)九连阴 2020年净利降6.65%至2.78亿元",
    "href": "http://stock.jrj.com.cn/2021/03/08105732090016.shtml",
    "datetime": "2021-03-08 10:57:48",
    "code": "300357"
  },
  {
    "title": "我武生物2020年度净利2.78亿下滑6.65% 研发费用增加",
    "href": "http://stock.jrj.com.cn/2021/03/05220932080602.shtml",
    "datetime": "2021-03-05 22:09:09",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)业绩快报：2020年净利降6.65%至2.78亿元",
    "href": "http://stock.jrj.com.cn/2021/03/05194232079846.shtml",
    "datetime": "2021-03-05 19:42:42",
    "code": "300357"
  },
  {
    "title": "我武生物股东张露减持20万股 套现约1832.6万",
    "href": "http://stock.jrj.com.cn/2021/02/24221632020802.shtml",
    "datetime": "2021-02-24 22:16:06",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：定增申请收到深交所审核问询函",
    "href": "http://stock.jrj.com.cn/2021/02/10191931884424.shtml",
    "datetime": "2021-02-10 19:19:09",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)：“黄花蒿花粉变应原舌下滴剂”获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/02/07175231861480.shtml",
    "datetime": "2021-02-07 17:52:42",
    "code": "300357"
  },
  {
    "title": "我武生物新药有望获批股价冲击涨停 摆脱产品单一格局或成增长新动力",
    "href": "http://stock.jrj.com.cn/2021/01/26081431773149.shtml",
    "datetime": "2021-01-26 08:14:02",
    "code": "300357"
  },
  {
    "title": "【龙虎榜】我武生物1月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/25180031767139.shtml",
    "datetime": "2021-01-25 18:00:00",
    "code": "300357"
  },
  {
    "title": "[我武生物]我武生物入选工信部第二批专精特新“小巨人”",
    "href": "http://stock.jrj.com.cn/2021/01/15000031698901.shtml",
    "datetime": "2021-01-15 00:00:00",
    "code": "300357"
  },
  {
    "title": "我武生物：根据公司战略发展需要 拟向全资子公司超级灵魂增资1.4亿元",
    "href": "http://stock.jrj.com.cn/2020/12/15190531496225.shtml",
    "datetime": "2020-12-15 19:05:38",
    "code": "300357"
  },
  {
    "title": "我武生物(300357.SZ)拟向超级灵魂增资1.4亿元",
    "href": "http://stock.jrj.com.cn/2020/12/15175131495427.shtml",
    "datetime": "2020-12-15 17:51:31",
    "code": "300357"
  },
  {
    "title": "我武生物净利十年增26倍股价累涨15倍 创新药单品市占率居首毛利率持续超90%",
    "href": "http://stock.jrj.com.cn/2020/11/23064331332136.shtml",
    "datetime": "2020-11-23 06:43:12",
    "code": "300357"
  },
  {
    "title": "我武生物拟募资不超7.25亿元",
    "href": "http://stock.jrj.com.cn/2020/11/18202731310722.shtml",
    "datetime": "2020-11-18 20:27:00",
    "code": "300357"
  },
  {
    "title": "我武生物2020年前三季度净利2.29亿下滑7.08% 研发费用增加",
    "href": "http://stock.jrj.com.cn/2020/10/22195131110398.shtml",
    "datetime": "2020-10-22 19:51:26",
    "code": "300357"
  },
  {
    "title": "[我武生物]关于建设项目竣工环境保护验收监测报告的公示",
    "href": "http://stock.jrj.com.cn/2020/10/12000031032329.shtml",
    "datetime": "2020-10-12 00:00:00",
    "code": "300357"
  },
  {
    "title": "[我武生物]三年蝉联,我武生物再次入选中国上市公司价值评选“创业板上市公司价值50强”",
    "href": "http://stock.jrj.com.cn/2020/09/11000030730519.shtml",
    "datetime": "2020-09-11 00:00:00",
    "code": "300357"
  },
  {
    "title": "我武生物2020年上半年净利1.07亿下滑17.95% 原有研发项目投入持续增加",
    "href": "http://stock.jrj.com.cn/2020/08/20102730547233.shtml",
    "datetime": "2020-08-20 10:27:46",
    "code": "300357"
  },
  {
    "title": "我武生物股东王立红拟减持股份 预计减持不超总股本0.36%",
    "href": "http://stock.jrj.com.cn/2020/05/07104229607951.shtml",
    "datetime": "2020-05-07 10:42:14",
    "code": "300357"
  },
  {
    "title": "我武生物2020年第一季度净利4136.87万下滑37.45% 营业收入减少、研发费用增加",
    "href": "http://stock.jrj.com.cn/2020/04/29190429422369.shtml",
    "datetime": "2020-04-29 19:04:38",
    "code": "300357"
  },
  {
    "title": "我武生物2020年第一季度净利3637.57万元-4960.33万元 研发投入增加",
    "href": "http://stock.jrj.com.cn/2020/03/27205329129952.shtml",
    "datetime": "2020-03-27 20:53:50",
    "code": "300357"
  },
  {
    "title": "我武生物：2019年净利2.98亿元 同比增长28%",
    "href": "http://stock.jrj.com.cn/2020/03/27185029129168.shtml",
    "datetime": "2020-03-27 18:50:08",
    "code": "300357"
  },
  {
    "title": "我武生物：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/03/27185029129163.shtml",
    "datetime": "2020-03-27 18:50:00",
    "code": "300357"
  },
  {
    "title": "我武生物：预计一季度净利润同比下降25%-45%",
    "href": "http://stock.jrj.com.cn/2020/03/27184229129152.shtml",
    "datetime": "2020-03-27 18:42:00",
    "code": "300357"
  },
  {
    "title": "我武生物：2019年净利2.98亿元 同比增28.14%",
    "href": "http://stock.jrj.com.cn/2020/02/28220728917558.shtml",
    "datetime": "2020-02-28 22:07:00",
    "code": "300357"
  },
  {
    "title": "我武生物2019年净利2.98亿增长28.14% 国内脱敏治疗市场扩大",
    "href": "http://stock.jrj.com.cn/2020/02/28183828916063.shtml",
    "datetime": "2020-02-28 18:38:47",
    "code": "300357"
  },
  {
    "title": "我武生物：2019年净利2.98亿元 同比增长28%",
    "href": "http://stock.jrj.com.cn/2020/02/28162428915162.shtml",
    "datetime": "2020-02-28 16:24:06",
    "code": "300357"
  },
  {
    "title": "我武生物：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/21073028710609.shtml",
    "datetime": "2020-01-21 07:30:03",
    "code": "300357"
  },
  {
    "title": "我武生物2019年度预计净利2.79亿元-3.26亿元 同比增长20%-40%",
    "href": "http://stock.jrj.com.cn/2020/01/20211128708048.shtml",
    "datetime": "2020-01-20 21:11:07",
    "code": "300357"
  },
  {
    "title": "我武生物：2019年净利预增20%-40%",
    "href": "http://stock.jrj.com.cn/2020/01/20210728708030.shtml",
    "datetime": "2020-01-20 21:07:00",
    "code": "300357"
  },
  {
    "title": "我武生物股东胡赓熙减持1367万股 套现约4.72亿元",
    "href": "http://stock.jrj.com.cn/2020/01/08195928645315.shtml",
    "datetime": "2020-01-08 19:59:40",
    "code": "300357"
  },
  {
    "title": "比茅台还暴利！我武生物4天跌20% 好股票又被外资抄底了？",
    "href": "http://stock.jrj.com.cn/2019/11/27073328455702.shtml",
    "datetime": "2019-11-27 07:33:20",
    "code": "300357"
  },
  {
    "title": "我武生物、康泰生物跌停 医药股怎么了？",
    "href": "http://stock.jrj.com.cn/hotstock/2019/11/23071728440778.shtml",
    "datetime": "2019-11-23 07:17:15",
    "code": "300357"
  },
  {
    "title": "我武生物高位跌停 机构资金博弈激烈",
    "href": "http://stock.jrj.com.cn/2019/11/22165928438662.shtml",
    "datetime": "2019-11-22 16:59:00",
    "code": "300357"
  },
  {
    "title": "我武生物11月22日盘中跌停",
    "href": "http://stock.jrj.com.cn/2019/11/22111528437147.shtml",
    "datetime": "2019-11-22 11:15:00",
    "code": "300357"
  },
  {
    "title": "我武生物：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/14220028245442.shtml",
    "datetime": "2019-10-14 22:00:04",
    "code": "300357"
  },
  {
    "title": "我武生物2019年前三季度净利约2.27亿–2.65亿 各项业务进展顺利",
    "href": "http://stock.jrj.com.cn/2019/10/14190228244651.shtml",
    "datetime": "2019-10-14 19:02:42",
    "code": "300357"
  },
  {
    "title": "我武生物新药品有望加速获批 未来销售规模将达到21.4亿元",
    "href": "http://stock.jrj.com.cn/2019/10/08084428212210.shtml",
    "datetime": "2019-10-08 08:44:00",
    "code": "300357"
  },
  {
    "title": "我武生物新药品有望加速获批 未来销售规模将达到21.4亿元",
    "href": "http://stock.jrj.com.cn/2019/10/08084428242017.shtml",
    "datetime": "2019-10-08 08:44:00",
    "code": "300357"
  },
  {
    "title": "我武生物：国家药监局对公司注册申报药品开展现场检查",
    "href": "http://stock.jrj.com.cn/2019/09/30165428201336.shtml",
    "datetime": "2019-09-30 16:54:31",
    "code": "300357"
  },
  {
    "title": "我武生物：国家药监局对公司注册申报药品开展现场检查",
    "href": "http://stock.jrj.com.cn/2019/09/30165228201329.shtml",
    "datetime": "2019-09-30 16:52:51",
    "code": "300357"
  },
  {
    "title": "我武生物2019年上半年盈利1.3亿 部分研发项目取得了阶段性进展",
    "href": "http://stock.jrj.com.cn/2019/08/14213427977492.shtml",
    "datetime": "2019-08-14 21:34:40",
    "code": "300357"
  },
  {
    "title": "我武生物：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/15134027841545.shtml",
    "datetime": "2019-07-15 13:40:00",
    "code": "300357"
  },
  {
    "title": "我武生物2019年上半年盈利1.2亿元至1.4亿元 同比增长20%-30%",
    "href": "http://stock.jrj.com.cn/2019/07/15115827841158.shtml",
    "datetime": "2019-07-15 11:58:34",
    "code": "300357"
  },
  {
    "title": "实控人胡赓熙拟在6个月内减持不超3% 我武生物跌停",
    "href": "http://stock.jrj.com.cn/2019/06/17141527714470.shtml",
    "datetime": "2019-06-17 14:15:12",
    "code": "300357"
  },
  {
    "title": "我武生物实控人胡赓熙拟减持157万股 该公司去年利润增长25%",
    "href": "http://stock.jrj.com.cn/2019/06/15175727708644.shtml",
    "datetime": "2019-06-15 17:57:43",
    "code": "300357"
  },
  {
    "title": "我武生物：实控人拟减持公司不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/06/14182227705900.shtml",
    "datetime": "2019-06-14 18:22:00",
    "code": "300357"
  },
  {
    "title": "我武生物：实控人胡赓熙拟在6个月内减持不超3%",
    "href": "http://stock.jrj.com.cn/2019/06/14181027705835.shtml",
    "datetime": "2019-06-14 18:10:13",
    "code": "300357"
  },
  {
    "title": "我武生物去年净利2.33亿元 同比增长25% 董事长胡赓熙年薪59万元",
    "href": "http://stock.jrj.com.cn/2019/03/29074527263515.shtml",
    "datetime": "2019-03-29 07:45:19",
    "code": "300357"
  },
  {
    "title": "我武生物：2018年净利同比增长25% 拟10送8派2.5元",
    "href": "http://stock.jrj.com.cn/2019/03/27213327252639.shtml",
    "datetime": "2019-03-27 21:33:35",
    "code": "300357"
  },
  {
    "title": "我武生物：2018年净利同比增25% 拟10送8派2.5元",
    "href": "http://stock.jrj.com.cn/2019/03/27212227252601.shtml",
    "datetime": "2019-03-27 21:22:00",
    "code": "300357"
  },
  {
    "title": "我武生物收到“黄花蒿粉滴剂” 儿童Ｉ期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2019/03/11121227146263.shtml",
    "datetime": "2019-03-11 12:12:52",
    "code": "300357"
  },
  {
    "title": "我武生物2018年净利最高2.42亿元 比上年同期增长30%",
    "href": "http://stock.jrj.com.cn/2019/01/29114126996291.shtml",
    "datetime": "2019-01-29 11:41:07",
    "code": "300357"
  },
  {
    "title": "我武生物：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/28231026993768.shtml",
    "datetime": "2019-01-28 23:10:00",
    "code": "300357"
  },
  {
    "title": "我武生物：2018年度净利预增20%-30%",
    "href": "http://stock.jrj.com.cn/2019/01/28164526992313.shtml",
    "datetime": "2019-01-28 16:45:00",
    "code": "300357"
  },
  {
    "title": "我武生物：引进投资方对我武干细胞增资1.37亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/08075926870951.shtml",
    "datetime": "2019-01-08 07:59:59",
    "code": "300357"
  },
  {
    "title": "我武生物：引进投资方对子公司我武干细胞增资",
    "href": "http://stock.jrj.com.cn/2019/01/07220526868513.shtml",
    "datetime": "2019-01-07 22:05:05",
    "code": "300357"
  },
  {
    "title": "[我武生物]畅迪进入美国PDR《医师桌上参考手册》",
    "href": "http://stock.jrj.com.cn/2018/12/02000030154198.shtml",
    "datetime": "2018-12-02 00:00:00",
    "code": "300357"
  },
  {
    "title": "[我武生物]我武生物荣膺“金牛奖最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2018/11/19000030154204.shtml",
    "datetime": "2018-11-19 00:00:00",
    "code": "300357"
  },
  {
    "title": "我武生物前三季度业绩预告 盈利预计增加20%–40%",
    "href": "http://stock.jrj.com.cn/2018/10/18075625218967.shtml",
    "datetime": "2018-10-18 07:56:00",
    "code": "300357"
  },
  {
    "title": "我武生物：前三季净利同比预增20%-40%",
    "href": "http://stock.jrj.com.cn/2018/10/15173525205158.shtml",
    "datetime": "2018-10-15 17:35:00",
    "code": "300357"
  },
  {
    "title": "我武生物：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/15173025205133.shtml",
    "datetime": "2018-10-15 17:30:01",
    "code": "300357"
  },
  {
    "title": "我武生物前三季度净利润预增20%-40%",
    "href": "http://stock.jrj.com.cn/2018/10/15162925204885.shtml",
    "datetime": "2018-10-15 16:29:13",
    "code": "300357"
  },
  {
    "title": "我武生物：脱敏治疗领域稀缺龙头",
    "href": "http://stock.jrj.com.cn/2018/09/09105525066222.shtml",
    "datetime": "2018-09-09 10:55:12",
    "code": "300357"
  },
  {
    "title": "重销售轻研发+产品线单一 如何撑起我武生物百亿市值",
    "href": "http://stock.jrj.com.cn/2018/09/03093825038455.shtml",
    "datetime": "2018-09-03 09:38:55",
    "code": "300357"
  },
  {
    "title": "我武生物董事长胡赓熙：脱敏市场布局基本完成 将发力干细胞领域",
    "href": "http://stock.jrj.com.cn/2018/08/17074924964941.shtml",
    "datetime": "2018-08-17 07:49:00",
    "code": "300357"
  },
  {
    "title": "我武生物上半年净利润同比增长32%",
    "href": "http://stock.jrj.com.cn/2018/08/14173224950693.shtml",
    "datetime": "2018-08-14 17:32:56",
    "code": "300357"
  },
  {
    "title": "[我武生物]第十二届“中国上市公司价值评选”,我武荣膺创业板上市公司价值五十强",
    "href": "http://stock.jrj.com.cn/2018/08/13000030154206.shtml",
    "datetime": "2018-08-13 00:00:00",
    "code": "300357"
  },
  {
    "title": "我武生物：中报预告略超预期，收入持续高增长",
    "href": "http://stock.jrj.com.cn/2018/07/11134724799637.shtml",
    "datetime": "2018-07-11 13:47:00",
    "code": "300357"
  },
  {
    "title": "我武生物：中报预告略超预期 收入持续高增长",
    "href": "http://stock.jrj.com.cn/2018/07/11102024798811.shtml",
    "datetime": "2018-07-11 10:20:00",
    "code": "300357"
  },
  {
    "title": "我武生物：十倍蓝海 独占鳌头",
    "href": "http://stock.jrj.com.cn/2018/06/25090424722101.shtml",
    "datetime": "2018-06-25 09:04:00",
    "code": "300357"
  },
  {
    "title": "我武生物：董事高管拟减持",
    "href": "http://stock.jrj.com.cn/2018/05/01164024475232.shtml",
    "datetime": "2018-05-01 16:40:00",
    "code": "300357"
  },
  {
    "title": "我武生物2017年度净利1.86亿元 拟10转增8股派4元",
    "href": "http://stock.jrj.com.cn/2018/03/14201324241755.shtml",
    "datetime": "2018-03-14 20:13:00",
    "code": "300357"
  },
  {
    "title": "我武生物：2018年一季度净利润预增25%-45%",
    "href": "http://stock.jrj.com.cn/2018/03/12201224229023.shtml",
    "datetime": "2018-03-12 20:12:00",
    "code": "300357"
  },
  {
    "title": "我武生物一季度业绩预增25%-45%",
    "href": "http://stock.jrj.com.cn/2018/03/12181624228360.shtml",
    "datetime": "2018-03-12 18:16:45",
    "code": "300357"
  },
  {
    "title": "我武生物：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/03/12181024228305.shtml",
    "datetime": "2018-03-12 18:10:00",
    "code": "300357"
  },
  {
    "title": "我武生物研发出“丝素蛋白保湿止痒敷料”",
    "href": "http://stock.jrj.com.cn/2017/11/30181923722341.shtml",
    "datetime": "2017-11-30 18:19:00",
    "code": "300357"
  },
  {
    "title": "我武生物：产品销售双维改善 进入加速成长期",
    "href": "http://stock.jrj.com.cn/hotstock/2017/04/12012122298257.shtml",
    "datetime": "2017-04-12 01:21:55",
    "code": "300357"
  },
  {
    "title": "我武生物：获得一项发明专利",
    "href": "http://stock.jrj.com.cn/hotstock/2014/07/15075917603396.shtml",
    "datetime": "2014-07-15 07:59:56",
    "code": "300357"
  },
  {
    "title": "次新股现涨停潮 我武生物等8股涨停",
    "href": "http://stock.jrj.com.cn/invest/2014/06/26112417492514.shtml",
    "datetime": "2014-06-26 11:24:00",
    "code": "300357"
  },
  {
    "title": "我武生物承担国家级重大专项子课题研究",
    "href": "http://stock.jrj.com.cn/2014/05/20205617251647.shtml",
    "datetime": "2014-05-20 20:56:00",
    "code": "300357"
  },
  {
    "title": "我武生物2013年净利增31% 拟10送6派3元",
    "href": "http://stock.jrj.com.cn/invest/2014/04/17205717066070.shtml",
    "datetime": "2014-04-17 20:57:00",
    "code": "300357"
  },
  {
    "title": "博雅应收款激增3.9倍 我武生物业绩变脸降30%",
    "href": "http://stock.jrj.com.cn/2014/04/14060717033049.shtml",
    "datetime": "2014-04-14 06:07:00",
    "code": "300357"
  },
  {
    "title": "快讯：我武生物午后拉升 大涨逾6%",
    "href": "http://stock.jrj.com.cn/2014/04/09142317008207.shtml",
    "datetime": "2014-04-09 14:23:56",
    "code": "300357"
  },
  {
    "title": "我武生物和天保重装两只次新股今日复牌",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/29065316592705.shtml",
    "datetime": "2014-01-29 06:53:50",
    "code": "300357"
  },
  {
    "title": "我武生物再涨停 上市3天涨逾76%",
    "href": "http://stock.jrj.com.cn/2014/01/23103016560461.shtml",
    "datetime": "2014-01-23 10:30:28",
    "code": "300357"
  },
  {
    "title": "酒业大亨“灌醉”我武生物 利益输送隐存超配疑窦",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/19140016532999.shtml",
    "datetime": "2014-01-19 14:00:11",
    "code": "300357"
  },
  {
    "title": "柳海彬“超配”我武生物 海际大和董事长赴京协查",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/15034816507452.shtml",
    "datetime": "2014-01-15 03:48:15",
    "code": "300357"
  },
  {
    "title": "阚治东投资我武生物三年溢价超16倍",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/13094816493758.shtml",
    "datetime": "2014-01-13 09:48:51",
    "code": "300357"
  },
  {
    "title": "我武生物尝存量发行头啖汤 阚治东等创投提前锁定收益",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/08055116464342.shtml",
    "datetime": "2014-01-08 05:51:39",
    "code": "300357"
  },
  {
    "title": "尉文渊阚治东“潜伏”我武生物",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/07060916456977.shtml",
    "datetime": "2014-01-07 06:09:31",
    "code": "300357"
  },
  {
    "title": "我武生物：领军本土变应原药 抢滩IPO缓解产能压力",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/02013016427997.shtml",
    "datetime": "2014-01-02 01:30:35",
    "code": "300357"
  },
  {
    "title": "我武生物支柱产品“畅迪”面临质疑",
    "href": "http://stock.jrj.com.cn/ipo/2012/11/05142014624055.shtml",
    "datetime": "2012-11-05 14:20:46",
    "code": "300357"
  }
]